Gene mutations and clinical prognosis of mucosal melanoma in different locations of head and neck

Acta Otolaryngol. 2022 Jan;142(1):94-99. doi: 10.1080/00016489.2021.2015540. Epub 2021 Dec 26.

Abstract

Background: Mucosal melanoma is the second most common subtype of melanoma in China and head and neck region is one of the main sites of this disease.

Aims/objectives: Analyzed the phenotypes of C-Kit, NRAS, PDGFRA and BRAF genes in patients with in different locations to explore the characteristics of gene mutations.

Material and methods: 96 patients were included in this study. C-Kit (exons 9, 11, 13, 17 and 18), NRAS (exons 1 and 2), PDGFRA (exons 12, 14 and 18) and BRAF (exons 11 and 15) were analyzed by PCR amplification and Sanger sequencing.

Results: 14 (14.58%) patients had C-Kit mutation, 6 (6.25%) had BRAF mutation, 23 (23.96%) had PDGFRA mutation, and 12 (12.50%) had NRAS mutation. The NRAS mutation (p = 0.037, 95%CI: 1.050-4.572) was an independent factor affecting distant metastasis and was most commonly found in the nasal cavity/paranasal sinuses (p = .043) while the BRAF mutation was more common in locations other than the nasal cavity/paranasal sinus (p = .008) and was associated with local recurrence.

Conclusions and significance: Gene phenotypes of mucosal melanoma in different locations has differences. Lesions in the nasal cavity and paranasal sinus should be assessed separately from other parts such as the nasopharynx.

Keywords: BRAF; C-kit; Head and neck mucosal melanoma; NRAS; PDGFRA; gene detection.

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • China
  • Female
  • Head and Neck Neoplasms / genetics*
  • Head and Neck Neoplasms / mortality*
  • Humans
  • Male
  • Melanoma / genetics*
  • Melanoma / mortality*
  • Middle Aged
  • Mutation
  • Phenotype
  • Prognosis